Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed - Related Studies

Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed

This study is ongoing, but not recruiting participants.

Study NCT00002583. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lung Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Non-Small-Cell Lung
		Lung Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		cisplatin
		vinorelbine ditartrate

5	Additional drug interventions recognized in this trial
		Vinblastine
		Vinorelbine

6	More general drug interventions related to this trial
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		National Cancer Institute of Canada
		National Cancer Institute (NCI)
		Southwest Oncology Group
		Eastern Cooperative Oncology Group
		Cancer and Leukemia Group B